AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16009290 — intervention group
Group type: COMPARATOR
Intervention: Primary healthcare follow-up (control group)
Number of subjects: 208
Study 12813449 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO 1.5 microg/kg on days 1, 3, and 5 before G-CSF
Number of subjects: 134
Study 12813449 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO 0.5 microg/kg on all 3 treatment days
Number of subjects: 134
Study 12813449 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO treatment
Number of subjects: 134
Study 12813449 — intervention group
Group type: COMPARATOR
Intervention: Placebo on days 1, 3, and 5 with G-CSF 5 microg/kg/day
Number of subjects: 134
Study 10564413 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified primary care
Number of subjects: 527
Study 10564413 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 527
Study 7474048 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic and imagery training (AT+IT)
Number of subjects: 39
Study 7474048 — intervention group
Group type: EXPERIMENTAL
Intervention: Music and imagery training (M+IT)
Number of subjects: 39
Study 7474048 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic, music and imagery training (AT+M+IT)
Number of subjects: 39
Study 7474048 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback (with all treatment groups)
Number of subjects: 39
Study 7474048 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft music (as a relaxation technique)
Number of subjects: 39
Study 7474048 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 39
Study 7474048 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 1754795 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis
Number of subjects: 0
Study 6755768 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg at 07h00, 13h00, and 19h00
Number of subjects: 12
Study 6755768 — intervention group
Group type: COMPARATOR
Intervention: Placebo at 07h00, 13h00, and 19h00
Number of subjects: 12
Study 30999080 — intervention group
Group type: EXPERIMENTAL
Intervention: PHT‐NLC‐hydrogel (0.5%w/v)
Number of subjects: 27
Study 30999080 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin hydrogel (0.5%w/v)
Number of subjects: 27
Study 30999080 — intervention group
Group type: COMPARATOR
Intervention: Blank hydrogel
Number of subjects: 27
Study 30241499 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led, telephone-based follow-up
Number of subjects: 871
Study 26646464 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiohelp system (Maquet Cardiopulmonary AG)
Number of subjects: 54
Study 26646464 — intervention group
Group type: EXPERIMENTAL
Intervention: Dideco ECC.O5 (Sorin Group)
Number of subjects: 54
Study 26646464 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltastream system with Hilite 7000 LT + DP3 pumphead (Medos Medizintechnik AG)
Number of subjects: 54
Study 26646464 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall extracorporeal membrane oxygenation therapy
Number of subjects: 54
Study 25035759 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal report provided by a research assistant (RA) to EPs after paramedics reported to the triage nurse.
Number of subjects: 279
Study 23572490 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcysteine 1200 mg
Number of subjects: 1395
Study 23572490 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 1395
Study 20617358 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) treatment for 24 weeks
Number of subjects: 0
Study 17705083 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasless laparoscopy
Number of subjects: 100
Study 17705083 — intervention group
Group type: COMPARATOR
Intervention: Minilaparotomy
Number of subjects: 100
Study 16368821 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg succinylcholine
Number of subjects: 180
Study 16368821 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg succinylcholine
Number of subjects: 180
Study 16368821 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg succinylcholine
Number of subjects: 180
Study 16368821 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg succinylcholine
Number of subjects: 180
Study 16368821 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg succinylcholine
Number of subjects: 180
Study 16368821 — intervention group
Group type: COMPARATOR
Intervention: saline solution (control group)
Number of subjects: 180
Study 12740693 — intervention group
Group type: EXPERIMENTAL
Intervention: Brilliant Dentin and Estilux Posterior for fillings and inlays; SR‐Isosit for inlays only
Number of subjects: 28
Study 12740693 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 28
Study 10678346 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine (10 mg) and methylprednisolone (40 mg) injection
Number of subjects: 60
Study 10678346 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine (10 mg) injection only
Number of subjects: 60
Study 8644684 — intervention group
Group type: EXPERIMENTAL
Intervention: Lauric acid diet
Number of subjects: 32
Study 8644684 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitic acid diet
Number of subjects: 32
Study 8644684 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 32
Study 8287989 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 52
Study 8287989 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 52
Study 8287989 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 52
Study 3524471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional alpha 2-interferon (IFN) 5 X 10(5) IU per dose, nine injections
Number of subjects: 27
Study 3524471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional alpha 2-interferon (IFN) 1 X 10(5) IU per injection
Number of subjects: 27
Study 3524471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional alpha 2-interferon (IFN) 1 X 10(4) IU per injection
Number of subjects: 27
Study 3524471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional alpha 2-interferon (IFN) 5 X 10(5) IU per injection, minimum of six injections
Number of subjects: 27
Study 3524471 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 27
Study 31679866 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoster Vaccine Live (ZVL)
Number of subjects: 981
Study 31679866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 981
Study 30459054 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 28
Study 30459054 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 28
Study 27778367 — intervention group
Group type: EXPERIMENTAL
Intervention: GR-MD-02 (galectin-3 inhibitor)
Number of subjects: 0
Study 27778367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25058414 — intervention group
Group type: EXPERIMENTAL
Intervention: Speeded intentionality judgments about grammatical subjects
Number of subjects: 0
Study 25058414 — intervention group
Group type: EXPERIMENTAL
Intervention: Unspeeded intentionality judgments about grammatical subjects
Number of subjects: 0
Study 25058414 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentionality judgments about grammatical subjects and objects in partially symmetric sentences
Number of subjects: 0
Study 25058414 — intervention group
Group type: EXPERIMENTAL
Intervention: Encouraged reflection on events described by sentences
Number of subjects: 0
Study 24711548 — intervention group
Group type: EXPERIMENTAL
Intervention: PINAOS (overall survival index)
Number of subjects: 572
Study 24711548 — intervention group
Group type: EXPERIMENTAL
Intervention: PINARFS (relapse-free survival index)
Number of subjects: 572
Study 22062774 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional verbal information plus second‐grade reading level brochure (Group 2)
Number of subjects: 0
Study 22062774 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional verbal information plus American Academy of Ophthalmology DVD (Group 4)
Number of subjects: 0
Study 22062774 — intervention group
Group type: COMPARATOR
Intervention: Conventional verbal information (Group 1)
Number of subjects: 0
Study 22062774 — intervention group
Group type: COMPARATOR
Intervention: Conventional verbal information plus eighth‐grade reading level brochure (Group 3)
Number of subjects: 0
Study 21056263 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic Acid (ZOL) 4 mg
Number of subjects: 422
Study 21056263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study 17444041 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV combined with intravitreous antibiotic drugs
Number of subjects: 30
Study 17444041 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV combined with silicone oil tamponade
Number of subjects: 30
Study 17444041 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 30
Study 16336695 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in the IL4 gene haplotypes
Number of subjects: 0
Study 16336695 — intervention group
Group type: EXPERIMENTAL
Intervention: Variation in the IL13 gene
Number of subjects: 0
Study 16336695 — intervention group
Group type: COMPARATOR
Intervention: Single SNPs in conserved non-coding elements
Number of subjects: 0
Study 12465659 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 Hz-modulated 450 MHz electromagnetic radiation (10-20 min, 0.158 mW cm(‐2))
Number of subjects: 100
Study 12465659 — intervention group
Group type: COMPARATOR
Intervention: Sham-exposed group
Number of subjects: 100
Study 10215750 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftibuten (9 mg kg(‐1))
Number of subjects: 50
Study 10215750 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime (8 mg kg(‐1))
Number of subjects: 50
Study 10215750 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg kg(‐1))
Number of subjects: 50
Study 8885951 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose indomethacin
Number of subjects: 431
Study 8885951 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 431
Study 1950147 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocktail group (100 ml of fluorescein mixture)
Number of subjects: 10
Study 1950147 — intervention group
Group type: COMPARATOR
Intervention: Fraction group (10 ml isolated fluorescein)
Number of subjects: 10
Study 6338906 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol 0.25%
Number of subjects: 28
Study 6338906 — intervention group
Group type: COMPARATOR
Intervention: timolol 0.5%
Number of subjects: 28
Study 30626354 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular bandage contact lens (BCL)
Number of subjects: 60
Study 30626354 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 60
Study 29766165 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA supplementation
Number of subjects: 0
Study 29766165 — intervention group
Group type: EXPERIMENTAL
Intervention: LIP supplementation
Number of subjects: 0
Study 27580080 — intervention group
Group type: EXPERIMENTAL
Intervention: Wedged insole group
Number of subjects: 48
Study 27580080 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 24183818 — intervention group
Group type: EXPERIMENTAL
Intervention: d-cycloserine (DCS) 50 mg
Number of subjects: 67
Study 24183818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 24183818 — intervention group
Group type: COMPARATOR
Intervention: Both DCS and Placebo
Number of subjects: 67
Study 22779378 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health education interventions (sample bag and/or video)
Number of subjects: 611
Study 22779378 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 611
Study 22779378 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 611
Study 21131257 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator-based driving-related training
Number of subjects: 69
Study 21131257 — intervention group
Group type: COMPARATOR
Intervention: Non-computer-based cognitive training
Number of subjects: 69
Study 17931065 — intervention group
Group type: EXPERIMENTAL
Intervention: HC‐SSW‐UVB (highly concentrated saline spa water baths followed by UVB)
Number of subjects: 160
Study 17931065 — intervention group
Group type: COMPARATOR
Intervention: UVB only
Number of subjects: 160
Study 15902792 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment
Number of subjects: 0
Study 15902792 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen treatment
Number of subjects: 0
Study 12479025 — intervention group
Group type: EXPERIMENTAL
Intervention: Seroxat 20 mg daily for four weeks
Number of subjects: 43
Study 12479025 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment observation after stopping Seroxat
Number of subjects: 43
Study 12479025 — intervention group
Group type: EXPERIMENTAL
Intervention: Side effects of Seroxat
Number of subjects: 43
Study 9805695 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl with 0.5% lidocaine (Group L + F) at doses of 0, 0.3, 1, 3, and 5 micrograms/kg
Number of subjects: 40
Study 9805695 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl alone (Group F) at doses of 1, 3, and 5 micrograms/kg
Number of subjects: 40
Study 9805695 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 3 micrograms/kg with 0.5% lidocaine
Number of subjects: 40
Study 7714348 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg controlled-release morphine sulfate tablet
Number of subjects: 25
Study 7714348 — intervention group
Group type: COMPARATOR
Intervention: 100 mg controlled-release morphine sulfate tablet
Number of subjects: 25
Study 1524367 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms/ml rPDGF-BB
Number of subjects: 20
Study 1524367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6343860 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 33
Study 6343860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 31667483 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocetin (10 mg per day)
Number of subjects: 50
Study 30239784 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-only strategy
Number of subjects: 782
Study 30239784 — intervention group
Group type: COMPARATOR
Intervention: Fresh embryo transfer (ET) strategy
Number of subjects: 782
Study 30239784 — intervention group
Group type: COMPARATOR
Intervention: Fresh ET strategy
Number of subjects: 782
Study 27042964 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 762
Study 27042964 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation
Number of subjects: 762
Study 24055627 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola rosea (RR) supplementation (600mg/day)
Number of subjects: 48
Study 22036839 — intervention group
Group type: EXPERIMENTAL
Intervention: ICP-targeted therapy with CM monitoring
Number of subjects: 60
Study 22036839 — intervention group
Group type: COMPARATOR
Intervention: CPP-targeted therapy
Number of subjects: 60
Study 22036839 — intervention group
Group type: EXPERIMENTAL
Intervention: CM monitoring for poor outcome
Number of subjects: 60
Study 22036839 — intervention group
Group type: EXPERIMENTAL
Intervention: CM monitoring for good outcome
Number of subjects: 60
Study 22036839 — intervention group
Group type: EXPERIMENTAL
Intervention: ICP-targeted therapy
Number of subjects: 60
Study 19131241 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrazole by continuous intravenous infusion
Number of subjects: 3
Study 19131241 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care or placebo
Number of subjects: 3
Study 19131241 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil
Number of subjects: 3
Study 17994402 — intervention group
Group type: EXPERIMENTAL
Intervention: Levalbuterol HFA 90 microg (two actuations of 45 microg) administered via metered dose inhaler (MDI) 30 minutes before exercise
Number of subjects: 15
Study 17994402 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered via metered dose inhaler (MDI) 30 minutes before exercise
Number of subjects: 15
Study 17994402 — intervention group
Group type: EXPERIMENTAL
Intervention: Levalbuterol HFA
Number of subjects: 15
Study 17994402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 16358372 — intervention group
Group type: EXPERIMENTAL
Intervention: Innocor (foreign gas rebreathing method)
Number of subjects: 34
Study 16358372 — intervention group
Group type: COMPARATOR
Intervention: Thermodilution
Number of subjects: 34
Study 16358372 — intervention group
Group type: COMPARATOR
Intervention: Echocardiography (CO(EC))
Number of subjects: 34
Study 16358372 — intervention group
Group type: COMPARATOR
Intervention: Left ventricle radiography (CO(LVR))
Number of subjects: 34
Study 12494136 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs (all 4 main classes)
Number of subjects: 0
Study 12494136 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 9876338 — intervention group
Group type: COMPARATOR
Intervention: 100 mg daily dose of DHEA for 6 months
Number of subjects: 19
Study 9876338 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo for 6 months
Number of subjects: 19
Study 7647820 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine (30 mg/day)
Number of subjects: 112
Study 7647820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 2536868 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant surgical resection after chemotherapy
Number of subjects: 72
Study 2536868 — intervention group
Group type: COMPARATOR
Intervention: No surgical resection (control group)
Number of subjects: 72
Study 790545 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 12
Study 790545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31574589 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified visual inhaler spacer usage guidelines
Number of subjects: 510
Study 31574589 — intervention group
Group type: COMPARATOR
Intervention: Unmodified visual inhaler spacer usage guidelines
Number of subjects: 510
Study 30256675 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual plus tactile stimuli
Number of subjects: 59
Study 30256675 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual, tactile plus haptic feedback stimuli
Number of subjects: 59
Study 30256675 — intervention group
Group type: COMPARATOR
Intervention: Visual stimuli only
Number of subjects: 59
Study 28235116 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy plus standard care (medical and nursing care with scheduled pharmacologic pain intervention)
Number of subjects: 60
Study 28235116 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 60
Study 28235116 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy plus standard care
Number of subjects: 60
Study 25612493 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m²)
Number of subjects: 280
Study 25612493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study 22958426 — intervention group
Group type: EXPERIMENTAL
Intervention: Taspoglutide 10 mg
Number of subjects: 760
Study 22958426 — intervention group
Group type: EXPERIMENTAL
Intervention: Taspoglutide 20 mg
Number of subjects: 760
Study 22958426 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone 45 mg
Number of subjects: 760
Study 21518942 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi exercise program (n = 50)
Number of subjects: 100
Study 21518942 — intervention group
Group type: COMPARATOR
Intervention: Time-matched education (n = 50, control group)
Number of subjects: 100
Study 19359536 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy (EIS)
Number of subjects: 1128
Study 19359536 — intervention group
Group type: COMPARATOR
Intervention: Selective invasive treatment strategy (SIS)
Number of subjects: 1128
Study 19359536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin C concentration in the third quartile
Number of subjects: 1128
Study 19359536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin C tertiles
Number of subjects: 1128
Study 16328192 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric squat training (bilateral leg extension at 70% of maximum voluntary contraction for 15 s per set, 10 sets/day, 4 days/week for 12 weeks)
Number of subjects: 8
Study 16328192 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric squat training
Number of subjects: 8
Study 15591013 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (2 and 4 grams per day)
Number of subjects: 0
Study 15591013 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 0
Study 11131232 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 10
Study 11131232 — intervention group
Group type: COMPARATOR
Intervention: Upright position
Number of subjects: 10
Study 9284980 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg twice daily)
Number of subjects: 25
Study 9284980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 8376471 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversational turn‐taking
Number of subjects: 48
Study 8376471 — intervention group
Group type: COMPARATOR
Intervention: Random responsiveness
Number of subjects: 48
Study 2874780 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketazolam once daily
Number of subjects: 14
Study 2874780 — intervention group
Group type: COMPARATOR
Intervention: Divided doses of ketazolam (from earlier study)
Number of subjects: 14
Study 29170944 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS targeting the insular cortex
Number of subjects: 8
Study 29170944 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS targeting the insular cortex
Number of subjects: 8
Study 29170944 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 8
Study 27919356 — intervention group
Group type: EXPERIMENTAL
Intervention: niacin monotherapy (N = 118)
Number of subjects: 552